FCM
PRAH

Frontier Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Frontier Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-896,923
Closed -$98.9M – 311
2019
Q1 		$98.9M Buy
896,923
+24,207
+3% +$2.53M 0.7% 38
2018
Q4 		$80.3M Buy
872,716
+163,707
+23% +$16.6M 0.65% 49
2018
Q3 		$78.1M Buy
+709,009
New +$73.8M 0.5% 66

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Frontier Capital Management's PRAH Position: Q2 2019 in Review

Frontier Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 896,923 shares — an estimated $98.9M sold.

Frontier Capital Management first reported a position in PRAH in Q3 2018 and held it in 3 quarters. The position peaked at $98.9M in Q1 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Frontier Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Frontier Capital Management sold 896,923 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $98.9M.
  • Frontier Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 3 quarters.
  • Frontier Capital Management's PRA Health Sciences, Inc. position peaked at $98.9M in Q1 2019.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Frontier Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.